Rheumatology Unit, Department of Clinical & Experimental Medicine, University of Perugia, Via Enrico Dal Pozzo, Perugia I-06122, Italy.
Ann Rheum Dis. 2013 Feb;72(2):286-92. doi: 10.1136/annrheumdis-2012-201511. Epub 2012 Aug 17.
It has been recently observed that a T-cell subset, lacking of both CD4 and CD8 molecules and defined as double negative (DN), is expanded in the blood of patients with systemic lupus erythematosus, produces IL-17 and accumulates in the kidney during nephritis. Since IL-17 production is enhanced in salivary gland infiltrates of primary Sjögren's syndrome (SS) patients, we investigated whether DN T cells may be involved in the pathogenesis of salivary gland damage.
Phenotypic characterisation of peripheral blood mononuclear cells from SS patients and controls was performed by flow cytometry in freshly isolated and anti-CD3-stimulated cells. SS minor salivary glands were processed for immunofluorescence staining.
CD3(+)CD4(-)CD8(-) DN T cells were major producers of IL-17 in SS and expressed ROR-γt. They were expanded in the peripheral blood, spontaneously produced IL-17 and infiltrated salivary glands. In addition, the expansion of αβ-TCR(+) DN T cells was associated with disease activity. Notably, IL-17-producing DN T cells from SS patients, but not from healthy controls, were strongly resistant to the in vitro effect of dexamethasone.
These findings appear to be of great interest since the identification of a peculiar T-cell subset with pro-inflammatory activity, but resistant to corticosteroids, in an autoimmune disorder such as SS may help to design new specific treatments for the disease.
最近观察到,系统性红斑狼疮患者血液中存在一种缺乏 CD4 和 CD8 分子的 T 细胞亚群,被定义为双阴性(DN),其数量增加,并在肾炎期间在肾脏中积累。由于原发性干燥综合征(SS)患者的唾液腺浸润中 IL-17 的产生增加,我们研究了 DN T 细胞是否可能参与唾液腺损伤的发病机制。
通过流式细胞术对 SS 患者和对照者的外周血单个核细胞进行表型特征分析,分别在新鲜分离和抗 CD3 刺激的细胞中进行。对 SS 小唾液腺进行免疫荧光染色。
CD3(+)CD4(-)CD8(-)DN T 细胞是 SS 中 IL-17 的主要产生细胞,并表达 ROR-γt。它们在外周血中扩增,自发产生 IL-17 并浸润唾液腺。此外,αβ-TCR(+)DN T 细胞的扩增与疾病活动相关。值得注意的是,来自 SS 患者而不是健康对照者的产生 IL-17 的 DN T 细胞对体外地塞米松的作用具有很强的抗性。
这些发现似乎非常有趣,因为在自身免疫性疾病(如 SS)中,鉴定出一种具有促炎活性但对皮质类固醇有抗性的特殊 T 细胞亚群,可能有助于为该疾病设计新的特异性治疗方法。